학술논문

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.
Document Type
Correction Notice
Source
Annals of Oncology. Oct2018, Vol. 29 Issue 10, p2152-2152. 1p.
Subject
*GENETIC mutation
*HER2 gene
*CLINICAL trials
Language
ISSN
0923-7534